Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-16 5:32 pm Purchase | 2024-08-08 | 13G | EXPION360 INC XPON | Altium Capital Management LLC | 15,000,000 9.990% | 15,000,000 (New Position) | Filing History |
| 2024-08-09 4:56 pm Purchase | 2024-08-05 | 13G | LOGICMARK INC PAR$ 04/ LGMK | Altium Capital Management LLC | 95,411 9.990% | 95,411 (New Position) | Filing History |
| 2024-08-09 4:52 pm Purchase | 2024-07-30 | 13G | SRX HEALTH SOLUTIONS, INC. SRXH | Altium Capital Management LLC | 345,000 5.800% | 345,000 (New Position) | Filing History |
| 2024-05-08 6:02 pm Purchase | 2024-05-01 | 13G | CEMTREX INC PAR $ 2023 CETX | Altium Capital Management LLC | 234 9.990% | 234 (New Position) | Filing History |
| 2024-02-21 4:28 pm Purchase | 2024-02-13 | 13G | SUNSHINE BIOPHARMA INC SBFM | Altium Capital Management LLC | 450 9.990% | 450 (New Position) | Filing History |
| 2024-02-20 4:38 pm Purchase | 2024-02-09 | 13G | EVOKE PHARMA INC EVOK | Altium Capital Management LLC | 153,186 9.700% | 153,186 (New Position) | Filing History |
| 2024-02-13 5:19 pm Sale | 2023-12-31 | 13G | VOLCON INC EMPD | Altium Capital Management LLC | 1,666,665 9.900% | -1,133,335 (-40.48%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | Altium Capital Management LLC | 3,626 4.990% | 3,626 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | GRI BIO INC GRI | Altium Capital Management LLC | 205 4.990% | 176 (+606.90%) | Filing History |
| 2024-02-13 5:15 pm Sale | 2023-12-31 | 13G | MARPAI INC MRAI | Altium Capital Management LLC | 0 0.000% | -451,332 (Position Closed) | Filing History |
| 2024-02-13 5:10 pm Purchase | 2023-12-31 | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LLC | 8,027,593 6.200% | 1,529,675 (+23.54%) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LLC | 809 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-13 3:27 pm Sale | 2023-12-31 | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LLC | 2,660,000 5.000% | -324,803 (-10.88%) | Filing History |
| 2024-02-02 6:09 pm Purchase | 2024-01-29 | 13G | SKYE BIOSCIENCE INC SKYE | Altium Capital Management LLC | 1,301,518 5.400% | 1,301,518 (New Position) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LLC | 809 8.000% | 809 (New Position) | Filing History |
| 2023-11-22 5:31 pm Purchase | 2023-11-16 | 13G | VOLCON INC EMPD | Altium Capital Management LLC | 2,800,000 9.900% | 2,800,000 (New Position) | Filing History |
| 2023-08-23 06:01 am Purchase | 2023-08-15 | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LLC | 2,984,803 5.700% | 2,984,803 (New Position) | Filing History |
| 2023-05-02 8:23 pm Purchase | 2023-04-24 | 13G | GRI BIO INC GRI | Altium Capital Management LLC | 29 9.990% | 29 (New Position) | Filing History |
| 2023-04-26 5:18 pm Purchase | 2023-04-17 | 13G | MARPAI INC MRAI | Altium Capital Management LLC | 451,332 6.200% | 451,332 (New Position) | Filing History |
| 2023-02-14 4:51 pm Unchanged | 2022-12-31 | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LLC | 6,497,918 5.700% | 0 (Unchanged) | Filing History |